Cancer Research

As many as 115 patients treated each day. Upwards of 5,000 people who have received life-saving cancer care since 2010. As impressive as these numbers are, the outcomes at the Roberts Proton Therapy Center are even more so.

A new imaging test may provide the ability to identify ovarian cancer patients who are candidates for an emerging treatment that targets a key enzyme cancer cells need to survive. Currently, epithelial ovarian cancer patients with BRCA1 mutations are considered candidates for the treatment, but there is no method to measure the enzyme levels to help guide treatment choices.

The wide-ranging discussion emphasized the importance of collaboration among researchers, the challenge of prevention, and the crucial importance of discovery and innovation in reaching milestones in cancer prevention and treatment.

The antibiotic vancomycin alters the gut microbiome in a way that can help prime the immune system to more effectively attack tumor cells after radiation therapy.

Researchers provide imagination and creativity. Penn provides the resources and infrastructure. This leads to what President Amy Gutmann calls “perfect impact.”